Clinical Trials · NCT06492330
Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Enrollment
- 62
- Start date
- Jul 2024
- Locations
- 1 site, China
- Primary endpoint
- Percentage change in body weight relative to baseline